# Publications

## 2025

- **Association Between ABCG2 Polymorphism and Statin-Induced Adverse Events: A Meta-Analysis**<br>*Lee Da, Shin Hae, Yoon Beom, Kim Woorim*<br>Cardiovascular Toxicology. 2025;25(11):1761--1767.

- **One-Year Risk of Bleeding in Patients on a Stable Warfarin Dose After Prosthetic Heart Valve Surgery**<br>*Min Kyung, Kim Woorim, Kim Jun, Gil Jin, Choi Kyung, Han Ji, Lee Kyung*<br>Pharmacoepidemiology and Drug Safety. 2025;34(9).

- **Factors inducing cutaneous adverse reactions in cancer patients treated with PD-1 and PD-L1 inhibitors: a machine-learning algorithm approach**<br>*Cho Young-Ah, Moon Youngyun, Park Wooyoung, Lee Yerin, Lee Kyung-Eun, Kim Dong-Chul, Kim Woorim*<br>Immunopharmacology and Immunotoxicology. 2025;47(1):53--58.

## 2024

- **Development of a Risk Prediction Model for Adverse Skin Events Associated with TNF-α Inhibitors in Rheumatoid Arthritis Patients**<br>*Kim Woorim, Oh Soo-Jin, Kim Hyun-Jeong, Kim Jun-Hyeob, Gil Jin-Yeon, Ku Young-Sook, Kim Joo-Hee, Kim Hyoun-Ah, Jung Ju-Yang, Choi In-Ah, Kim Ji-Hyoun, Kim Jinhyun, Han Ji-Min, Lee Kyung-Eun*<br>Journal of Clinical Medicine. 2024;13(14).

- **Risk factors for hyperglycemia in COVID-19 patients treated with remdesivir**<br>*Kim Woorim, Lee Go, Rhee Nuga, Min Kyung, Kim Jun, Gil Jin, Lee Kyung*<br>Clinical and Translational Science. 2024;17(1):e13684.

## 2023

- **Machine Learning Approaches for Assessing Risk Factors of Adrenal Insufficiency in Patients Undergoing Immune Checkpoint Inhibitor Therapy**<br>*Kim Woorim, Cho Young, Min Kyung, Kim Dong-Chul, Lee Kyung-Eun*<br>Pharmaceuticals. 2023;16(8):1097.

- **Association between SYVN1 and SEL1 genetic polymorphisms and remission in rheumatoid arthritis patients treated with TNF-α inhibitors: a machine learning approach**<br>*Kim Woorim, Yeon Ha, Kim Jun, Kim Joo, Kim Hyoun-Ah, Jung Ju-Yang, Choi In, Lee Kyung*<br>Immunologic Research. 2023;71(5):709--716.

## 2022

- **Effects of RETN polymorphisms on treatment response in rheumatoid arthritis patients receiving TNF-α inhibitors and utilization of machine-learning algorithms**<br>*Kim Woorim, Oh Soo, Trinh Nga, Choi Yunjeong, Kim Jun, Kim Hyoun-Ah, Jung Ju-Yang, Choi In, Lee Kyung*<br>International Immunopharmacology. 2022;111:109094.

- **COVID-19 Prognosis in Association with Antidepressant Use**<br>*Min Kyung, Kim Tae, Oh Soo, Kim Woorim, Lee Kyung*<br>Pharmacopsychiatry. 2022;55(04):220--227.

- **Association between Genetic Polymorphism of GSTP1 and Toxicities in Patients Receiving Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis**<br>*Kim Woorim, Cho Young-Ah, Kim Dong-Chul, Lee Kyung-Eun*<br>Pharmaceuticals. 2022;15(4):489.

- **Elevated Risk of Fluoropyrimidine-Associated Toxicity in European Patients with DPYD Genetic Polymorphism: A Systematic Review and Meta-Analysis**<br>*Kim Woorim, Cho Young-Ah, Kim Dong-Chul, Lee Kyung-Eun*<br>Journal of Personalized Medicine. 2022;12(2):235.

- **Association between nuclear factor of activated T cells C2 polymorphisms and treatment response in rheumatoid arthritis patients receiving tumor necrosis factor-alpha inhibitors**<br>*Kim Woorim, Kim Hyun, Trinh Nga, Yeon Ha, Kim Joo, Choi In, Kim Hyoun-Ah, Jung Ju-Yang, Lee Kyung*<br>Pharmacogenetics and Genomics. 2022;32(1):10--15.

## 2021

- **Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models**<br>*Kim Woorim, Cho Young-Ah, Kim Dong-Chul, Jo A-Ra, Min Kyung-Hyun, Lee Kyung-Eun*<br>Cancers. 2021;13(21):5465.

- **Association of TLR 9 gene polymorphisms with remission in patients with rheumatoid arthritis receiving TNF-α inhibitors and development of machine learning models**<br>*Kim Woorim, Kim Tae, Oh Soo, Kim Hyun, Kim Joo, Kim Hyoun-Ah, Jung Ju-Yang, Choi In, Lee Kyung*<br>Scientific Reports. 2021;11(1):20169.

- **TGF-β1 polymorphism increases the risk of bleeding complications in patients on oral anticoagulant after cardiac valve replacement**<br>*Kim Woorim, Yee Jeong, Chang Byung-Chul, Gwak Hye*<br>Heart and Vessels. 2021;36(12):1885--1891.

- **Association of risk factors and bleeding complications in Asian patients taking edoxaban**<br>*Lee Ok, Kim Woorim, Jang Bo, Min Kyung, Cho Yoon, Lee Myung, Lee Kyung*<br>British Journal of Clinical Pharmacology. 2021;87(4):2121--2127.

